$FENC News

B. Riley Securities Reiterates Buy on Fennec Pharmaceuticals, Raises Price Target to $18

Wedbush Maintains Outperform on Fennec Pharmaceuticals, Raises Price Target to $16

Fennec: The Turnaround Is Real, But The Stock Prices In Perfection (Downgrade)

Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript

Fennec Pharmaceuticals Q2 EPS $0.05 Beats $0.02 Estimate, Sales $17.874M Beat $16.095M Estimate

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Fennec Announces Results of Annual Meeting

Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting

HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $16

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Fennec Pharmaceuticals Inc (FENC) Q1 2026 Earnings Call Highlights: Record Sales Surge and ...

Adherex Technologies Q1 Earnings Call Highlights

Fennec Pharmaceuticals Shares Rise After Earnings and Revenue Beat Forecasts (FENC)

Fennec Pharmaceuticals up 12.6% in U.S. Pre-Market on Q1 Earnings as Pedmark Sales Jump 73%

Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates

Fennec Pharmaceuticals (NASDAQ:FENC) Q1 Beat Overshadowed by Surging Costs

Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

Fennec Pharmaceuticals Reports Q1 2026 Results: Full Earnings Call Transcript

Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting